Publications by authors named "Aude Ferran"

Claim this Profile
M
Minimum inhibitory concentrations of sulfonamides and trimethoprim for veterinary pathogens: New data for old antibiotics.
Nadine Ruchti, Aude A Ferran, Andrew Mead, Ludovic Pelligand, Alexis Viel

Vet Microbiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling of sulfadimethoxine, sulfadiazine and sulfamethoxazole combined to trimethoprim in pigs.
Marine Boulanger, Jean-François Taillandier, Jérôme Henri, Mathias Devreese, Siegrid De Baere, Aude A Ferran

Vet Q· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessment of extracellular and intracellular activity of macrolides, rifampicin, and doxycycline against based on bacterial counts and microscopy.
Anne-Sophie Huguet, Ophélie Gourbeyre, Alain Bousquet-Mélou, Aude A Ferran, Elodie A Lallemand

Microbiol Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Cutoff Values for Doxycycline in Pigs to Support the Establishment of Clinical Breakpoints for Antimicrobial Susceptibility Testing.
Pierre-Louis Toutain, Alain Bousquet-Melou, Aude A Ferran, Béatrice B Roques, Jérôme R E Del Castillo

J Vet Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs.
Jérémy Béguin, Sarra Mahfoudhi, Marie Uzel, Antoine Rostang, Catherine Ibish, Aude A Ferran

BMC Vet Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers.
Marine Boulanger, Jean-François Taillandier, Jérôme Henri, Mathias Devreese, Siegrid De Baere, Aude A Ferran

Poult Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against at concentrations achievable in foals.
Anne-Sophie Huguet, Ophélie Gourbeyre, Agathe Bernand, Charline Philibert, Alain Bousquet-Melou, Aude A Ferran

Front Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sub-MIC selective window decreases along the digestive tract: determination of the minimal selective concentration of oxytetracycline in sterilised intestinal contents.
Pedro Henrique Imazaki, Bertille Voisin, Nathalie Arpaillange, Béatrice B Roques, Emilie Dordet-Frisoni, Aude A Ferran

Front Microbiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted efficacy and tolerance of different dosage regimens of benzylpenicillin in horses based on a pharmacokinetic study with three IM formulations and one IV formulation.
Aude A Ferran, Béatrice B Roques, Laura Chapuis, Taisuke Kuroda, Marlène Z Lacroix

Front Vet Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an biofilm model for the study of the impact of fluoroquinolones on sewer biofilm microbiota.
Sarah A Naudin, Aude A Ferran, Pedro Henrique Imazaki, Nathalie Arpaillange, Camille Marcuzzo

Front Microbiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial combinations against including benzoxadiazol-based flavodoxin inhibitors: characterization.
Lilha Beyria, Ophelie Gourbeyre, Sandra Salillas, Alejandro Mahía, María Dolores Díaz de Villegas, Aude A Ferran

Microbiol Spectr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses.
Elodie A Lallemand, Alain Bousquet-Mélou, Laura Chapuis, Jennifer Davis, Aude A Ferran

Front Microbiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biased computation of probability of target attainment for antimicrobial drugs.
Pierre-Louis Toutain, Peggy Gandia, Ludovic Pelligand, Aude A Ferran, Peter Lees

CPT Pharmacometrics Syst Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination.
Aude A Ferran, Marlène Z Lacroix, Ophélie Gourbeyre, Alicia Huesca, Baptiste Gaborieau

Microbiol Spectr· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 3: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 4: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 5: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 6: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 7: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 8: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 9: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 10: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 11: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 12: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 13: .

EFSA J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis